Genetix Pharmaceuticals Secures $35M in Series B Funding
March 18, 2010 by biotechconnection.com · Leave a Comment
Genetix Pharmaceuticals Secures $35M in Series B Funding
CAMBRIDGE, Mass.—-Genetix Pharmaceuticals, a leading gene therapy company developing breakthrough treatments for severe genetic disorders, announced today that it has completed a $35 million Series B financing with new investors Third Rock Ventures and Genzyme Ventures joining TVM Capital, Forbion and Easton Capital.
Read more on Business Wire via Yahoo! Finance